The particularity of paediatric cancers being rare diseases necessitates a collaborative approach to collate and integrate the data collected in all member states, including best practices and new technologies in order to further develop common solutions. The use of big data for better insights in cancer genesis, outcomes and the long-term side effects of treatments is currently under-developed.
Artificial intelligence and machine learning are powerful tools allowing for complex data analytics on large-scale data sets with great potential for fostering precision cancer medicine for all young people in Europe. Further advances in the diagnosis and treatment of paediatric oncology will require multinational, multidisciplinary integrated healthcare and research data platforms that will allow real world data simulations of machine-learning algorithms and artificial intelligence that can be exploited in data-driven clinical decision support applications that directly benefit patients.
Scope
The European Commission adopted on 04 May 2021 a decision on on the financing of pilot projects and preparatory actions in the field of „Communications Networks, Content and Technology” and on the adoption of the work programme for 2021 (C(2021) 3006 final).
Paediatric cancers are a collection of diverse rare diseases that together represent individually life-threatening diseases and collectively a major public health issue. With 35,000 new cases and more than 6,000 children and young people dying each year in Europe, paediatric cancer remains the leading cause of death from disease for children and adolescents. Two-thirds of survivors live with the long-term treatment-related side effects that can be severe and impact on the daily life of half of those affected.
Expected Impact:
- The project will support research and innovation and further collaboration on artificial intelligence technologies applied for diagnosis and treatment of paediatric cancers. Project results are expected to cover a representative range of stakeholders and solutions across EU/EEA countries, with a particular focus on patients, carers and survivors. The project is expected to create synergies and complement the activities under the pilot project funded from the previous call (PPPA-AIPC-2020).
Conditions
1. Admissibility conditions: described in section 5 of the call document
Proposal page limits and layout: described in Part B of the Application Form available in the Submission System
2. Eligible countries: described in section 6 of of the call document
3. Other eligibility conditions: described in section 6 of the call document
4. Financial and operational capacity and exclusion: described in section 7 of the call document
5. Evaluation and award
6. Legal and financial set-up of the grants: described in section 10 of the call document
Deadline date: 03 August 2021 17:00:00 Brussels time
Call documents:
